Heinz Gisslinger

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 132 publications

A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia.

A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia.

Journal: American journal of hematology

Published: July 03, 2025

Optimizing Belantamab Mafodotin in Relapsed or Refractory Multiple Myeloma: Impact of Dose Modifications on Adverse Events and Hematologic Response in a Real-World Retrospective Study.

Optimizing Belantamab Mafodotin in Relapsed or Refractory Multiple Myeloma: Impact of Dose Modifications on Adverse Events and Hematologic Response in a Real-World Retrospective Study.

Journal: Cancers

Published: June 23, 2025

Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera.

Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera.

Journal: Blood cancer journal

Published: March 24, 2025

Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).

Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).

Journal: HemaSphere

Published: January 28, 2025

Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms.

Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 23, 2025

Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxis.

Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxis.

Journal: Research and practice in thrombosis and haemostasis

Published: January 12, 2025

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

Journal: Blood

Published: November 07, 2024

Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis.

Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis.

Journal: Blood

Published: June 20, 2024

Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcome.

Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcome.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 08, 2024

Change in Polycythemia Vera Treatment: Ropeginterferon Alfa-2b in Light of Current Trials

Change in Polycythemia Vera Treatment: Ropeginterferon Alfa-2b in Light of Current Trials

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: December 05, 2023

Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.

Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.

Journal: European journal of haematology

Published: May 26, 2023

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach.

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach.

Journal: Blood cancer journal

Published: May 18, 2023

Showing 1-12 of 132

Last Updated: 09/26/2026